Healthcare -
Biotechnology - NASDAQ - US
$ 9.08
4.73 %
$ 531 M
Market Cap
-3.27
P/E
CGEM - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities CGEM - Cullinan Oncology, Inc.
35.8 M
LAST VALUE
45.16%
2 YEAR CAGR
168.36%
5 YEAR CAGR
0.00%
10 YEAR CAGR